Sinopharm Group Co. Ltd. (FRA:X2S)
Germany
· Delayed Price · Currency is EUR 1.959
-0.022 (-1.11%)
Last updated: Apr 17, 2025
Sinopharm Group Revenue
In the year 2024, Sinopharm Group had annual revenue of 584.51B CNY, down -2.02%. Sinopharm Group had revenue of 144.89B in the quarter ending December 31, 2024, a decrease of -3.82%.
Revenue
584.51B CNY
Revenue Growth
-2.02%
P/S Ratio
0.08
Revenue / Employee
5.40M CNY
Employees
108,217
Market Cap
6.32B EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
| Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
| Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
| Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
| Dec 31, 2020 | 456.41B | 31.14B | 7.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 34.18B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Deutsche Börse AG | 5.80B |
| Merck KGaA | 21.16B |